Axogen, Inc. to present at the Jefferies Virtual Healthcare Conference and the JMP Securities Life Sciences Conference May 18, 2022
Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft May 4, 2022
Axogen, Inc. to Report First Quarter 2022 Financial Results and Host Conference Call on May 4, 2022 Apr 13, 2022
Axogen, Inc. to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on February 22, 2022 Feb 2, 2022
